ArticleMedicine, health care, and philosophy2014
Alzheimer, dementia and the living will: a proposal.
Article in Medicine, health care, and philosophy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Expert Consensus on the Care and Management of Patients with Cognitive Impairment in China.Neuroscience bulletin · 2020Pooled it
- Estimation of the Cognitive Functioning of the Elderly by AI Agents: A Comparative Analysis of the Effects of the Psychological Burden of Intervention.Healthcare (Basel, Switzerland) · 2024Article
- Smartwatch-Based Interventions for People With Dementia: User-Centered Design Approach.JMIR aging · 2024Article
- Portuguese Advance Directives-a twist against futility? A cross sectional study.Sao Paulo medical journal = Revista paulista de medicina · 2024Article
- A Review on the Use of Modern Computational Methods in Alzheimer's Disease-Detection and Prediction.Current Alzheimer research · 2024Review
- New Community and Sociohealth Challenges Arising from the Early Diagnosis of Mild Cognitive Impairment (MCI).Journal of personalized medicine · 2023Review
- Practices and perspectives of primary care physicians in Japan and the United States about diagnosing dementia: a qualitative study.BMC geriatrics · 2021Article
- Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB.Pharmaceutics · 2021Review
- New taxonomy for prolonged disorders of consciousness may help with decisions on withdrawal of clinically assisted nutrition and hydration: A proposed decision-making pathway.Journal of rehabilitation medicine · 2021Article
- End-of-Life Decisions in Albania: The Call for an Ethical Revision.The Liverpool law review · 2020Article
- Health Outcome Prioritization in Alzheimer's Disease: Understanding the Ethical Landscape.Journal of Alzheimer's disease : JAD · 2020Review
- Empowering Patients with Alzheimer's Disease To Avoid Unwanted Medical Care: A Look At The Dementia Care Triad.American journal of Alzheimer's disease and other dementias · 2018Article
- Advance care planning in dementia: recommendations for healthcare professionals.BMC palliative care · 2018Review
- Effects of Lignans from Schisandra chinensis Rattan Stems against AβMolecules (Basel, Switzerland) · 2018Article
- Advance directives as a tool to respect patients' values and preferences: discussion on the case of Alzheimer's disease.BMC medical ethics · 2018Article
- Severe head injury in very old patients: to treat or not to treat? Results of an online questionnaire for neurosurgeons.Neurosurgical review · 2018Article
- Psychometric Evaluation of the Cognitive State Test (COST) in a Sample of Iranian Elderly People.Iranian Red Crescent medical journal · 2016Article
- Palliative care and the Portuguese health system.Porto biomedical journalReview
- Ethnographic Exploration of Empowerment to Improve Elderly Residents' Quality of Life.Iranian journal of nursing and midwifery researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The world population aged significantly over the twentieth century, leading to an increase in the number of individuals presenting progressive, incapacitating, incurable chronic-degenerative diseases. Advances in medicine to prolong life prompted the establishment of instruments to ensure their self-determination, namely the living will, which allows for an informed person to refuse a type of treatment considered unacceptable according to their set of values. From the knowledge on the progression of Alzheimer disease, it is possible to plan the medical care, even though there is still no treatment available. Irreversible cognitive incapacity underlines the unrelenting loss of autonomy of the demented individual. Such a loss requires the provision of specific and permanent care. Major ethical issues are at stake in the physician-patient-family relationship, even when dementia is still at an early stage. The authors suggest that for an adequate health care planning in Alzheimer disease the living will can be presented to the patient in the early days of their geriatric care, as soon as the clinical, metabolic or even genetic diagnosis is accomplished. They also suggest that the appointment of a health care proxy should be done when the person is still in full enjoyment of his cognitive ability, and that the existence and scope of advance directives should be conveyed to any patient in the early stages of the disease. It follows that ethical guidelines should exist so that neurologists as well as other physicians that deal with these patients should discuss these issues as soon as possible after a diagnosis is reached.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.